Fresenius markets €1.2bn loans, sets guidance
Fresenius, the German healthcare company, marketed on Monday its new €1.2bn loan package in Frankfurt, after setting margin and original issue discount guidance on the term loan ‘B’ tranche late last week.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast